Eyewire Today

Date: January 3, 2011

Interview with CEO of Allergan, Sir David Pyott

From EyetubeTV

Date:October 27, 2010

Interview with Bausch + Lomb Surgical CEO Robert Grant

From Eyewire Today

Robert Grant, president and chief executive officer of Bausch + Lomb's Global Surgical business, spoke with Eyewiretoday.com at the American Academy of Ophthalmology meeting in Chicago.

Mr. Grant, who assumed his new role on August 1, 2010, said Bausch + Lomb's surgical unit will focus on innovation in the eye care market, specifically in therapeutics and medical devices aimed toward patients with age-related diseases and diabesity. This focus will include presbyotic correction, cataract surgery, medical devices related to glaucoma, age-related macular degeneration, diabetic retinopathy and diabetic macular edema, Mr. Grant said.

He added that Bausch and Lomb's goal over the next five years is to create a better overall experience for patients, meaning "less down time, microincisions, less invasive procedures moving toward non-invasive procedures, greater degree of precision with those procedures, and a marriage of diagnostic and therapy."

When asked about his thoughts on femtosecond laser technology for use in cataract surgery, Mr. Grant said he thought there was great potential for its use and application.

"We saw what femtosecond laser technology did to the microkeratome space in LASIK flap cutting back earlier in this decade. I think there's a potential that femtosecond laser technology, once proven, is going to be able to do something similar for cataract surgery. It's probably not likely to be the panacea, however, I believe that it could drive a paradigm shift and transform the industry around cataract to drive better outcomes."

Date:June 28, 2010

Ophthalmologists Travel to Peru to Offer Cataract Relief

From eyetube

Frank Bucci, MD, in conjunction with the Clinton Foundation, traveled to Peru to help tackle the cataract epidemic.

June 1, 2010

Innovation and the Future of Industry

From EyetubeTV

EyetubeTV sits down with business magnates Bill Link and Andy Corley to get their perspectives on the challenges facing innovation in ophthalmology and where they expect technology to evolve over the coming years.

April 27, 2010

Combination Drug-Laser Therapy Shows Great Promise in Treating DME

From Retina Today

Breakthrough research has shown that ranibizumab (Lucentis, Genentech, Inc.) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for treating diabetic macular edema (DME).1The National Institutes of Health (NIH) study, publisher...Read related article

March 10

Status of the Refractive Industry

From Market Scope, LLC

Dave Harmon, founder and president of Market Scope LLC, speaks at the Aspen Invitational Refractive Symposium Conference (AIRS) in Aspen, Colorado, about the status of the refractive industry. While laser refractive surgery in the United States is down about 45 percent from 2000, Mr. Harmon said there are indications the laser correction market is turning around.